Medical treatment of female overactive bladder syndrome and treatment-related effects

作者: Sheng-Mou Hsiao , Ho-Hsiung Lin

DOI: 10.1016/J.JFMA.2018.01.011

关键词: Overactive bladder syndromeMedicineAdverse effectUrodynamic studiesUrine biomarkersUrologyUrinary bladderVaginal estrogenMedical treatment

摘要: The age-adjusted prevalence of overactive bladder syndrome (OAB) in Taiwan is approximately 16.9%. Currently, a variety treatments are available for female OAB. However, different have treatment-related effects that may lead to significant adverse and ineffective treatment. In this article, we reviewed the tools can be used evaluate efficacy OAB treatments, such as questionnaires, serum or urine biomarkers, diaries urodynamic studies. addition, medications treatment, antimuscarinics, beta-3 agonists, onabotulinumtoxinA intradetrusor injections, topical vaginal estrogen therapy instillation liposome-encapsulated onabotulinumtoxinA. We focused on their any effects. information review should useful guide treatment patients.

参考文章(104)
H. Y. Chin, H. Y. Chin, K. C. Lin, C. J. Wang, C. H. Chiang, Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders. Clinical and Experimental Obstetrics & Gynecology. ,vol. 39, pp. 171- 174 ,(2012)
S. A. Shumaker, J. F. Wyman, J. S. Uebersax, D. McClish, J. A. Fantl, , Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory Quality of Life Research. ,vol. 3, pp. 291- 306 ,(1994) , 10.1007/BF00451721
Kat suya Hikita, Masashi Honda, Shinji Hirano, Bunya Kawamoto, Tsounapi Panagiota, Kuniyasu Muraoka, Takehiro Sejima, Atsushi Takenaka, Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries. Neurourology and Urodynamics. ,vol. 35, pp. 349- 353 ,(2016) , 10.1002/NAU.22719
Hann-Chorng Kuo, Kyu-Sung Lee, Yanqun Na, Rajeev Sood, Shigeru Nakaji, Yosuke Kubota, Kentarou Kuroishi, Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder in Asia Neurourology and Urodynamics. ,vol. 34, pp. 685- 692 ,(2015) , 10.1002/NAU.22645
Karl-Erik Andersson, Chaitanya Sarawate, Kristijan H. Kahler, Elizabeth L. Stanley, Amit S. Kulkarni, Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder BJUI. ,vol. 106, pp. 268- 274 ,(2009) , 10.1111/J.1464-410X.2009.09073.X
Nancy N. Maserejian, Varant Kupelian, Kevin T. McVary, Meena Doshi, Carol L. Link, John B. McKinlay, Prevalence of post-micturition symptoms in association with lower urinary tract symptoms and health-related quality of life in men and women. BJUI. ,vol. 108, pp. 1452- 1458 ,(2011) , 10.1111/J.1464-410X.2010.10014.X
Varant Kupelian, Raymond C. Rosen, Claus G. Roehrborn, Pradeep Tyagi, Michael B. Chancellor, John B. McKinlay, Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJUI. ,vol. 110, pp. 401- 407 ,(2012) , 10.1111/J.1464-410X.2011.10769.X
Tsia-Shu Lo, Ling-Hong Tseng, Yi-Hao Lin, Ching-Chung Liang, Ching-Yi Lu, Leng Boi Pue, Effect of extracorporeal magnetic energy stimulation on bothersome lower urinary tract symptoms and quality of life in female patients with stress urinary incontinence and overactive bladder. Journal of Obstetrics and Gynaecology Research. ,vol. 39, pp. 1526- 1532 ,(2013) , 10.1111/JOG.12090